Infinite Epigenetics Acquires Tally Health to Build Epigenetic Data Platform for Longevity Infinite Epigenetics, the parent company of TruDiagnostic, has acquired Tally Health, the consumer longevity company co-founded by Harvard geneticist Dr. David Sinclair, in what the company says is the largest acquisition in epigenetic age testing to date. Read More from the Global Wellness News ™
Longevity Science Is Overhyped. But This Research Really Could Change Humanity
Read More from the Global Wellness News ™
Stanford AI startup seeks $100m at $1b valuation
Stanford AI startup seeks $100m at $1b valuation Human Intelligence plans to collaborate with Kernel, a neurotech company making neural activity headsets. Read More from the Global Wellness News ™
ATN Week in Review: As Fitness Goes Global, US Brands Face Heightened Competition
ATN Week in Review: As Fitness Goes Global, US Brands Face Heightened Competition European fitness brands are increasingly entering the U.S., a phenomenon that’s likely to accelerate in the years ahead. Read More from the Global Wellness News ™
The Rich and Powerful Want to Live Forever. What if They Could?
Read More from the Global Wellness News ™
The Biggest Sustainability Trends in Travel for 2026
The Biggest Sustainability Trends in Travel for 2026 From rewilding vast expanses of land to AI-driven reductions in food waste, these are the latest trends and advancements in the travel industry protecting-and regenerating-planet Earth. Read More from the Global Wellness News ™
What to Know About the U.K.’s Generational Smoking Ban
What to Know About the U.K.’s Generational Smoking Ban Those in the U.K. born in 2009 and after will never be able to buy cigarettes. Read More from the Global Wellness News ™
Women’s Health to Hit $600B in Shift to Lifelong Care
Women’s Health to Hit $600B in Shift to Lifelong Care The category is evolving to include conditions that affect women uniquely, disproportionately, and differently from men. Read More from the Global Wellness News ™
Osteoboost Raises $8M To Scale Wearable Targeting Bone Loss in Women
Osteoboost Raises $8M To Scale Wearable Targeting Bone Loss in Women Osteoboost, an FDA-cleared wearable that slowed bone-density loss by 85% in clinical trials, just raised $8 million. Read More from the Global Wellness News ™
ONTO Health Raises $20M Series A for AI-Enabled Fertility and Longevity Care; Announces Gulf Region Expansion
ONTO Health Raises $20M Series A for AI-Enabled Fertility and Longevity Care; Announces Gulf Region Expansion ONTO Health, an AI-enabled, physician-led fertility and longevity provider, has closed a $20 million Series A co-led by healthcare investors ARTIS and Humania. The funding will support expanded clinical operations in the U.S. and expansion into the Gulf Cooperation Council (GCC) region. Read More from the Global Wellness News…